Page 20 - TD-3-2
P. 20

Tumor Discovery                                                Volatile organic compounds for cancer screening



               2020;362(13):1192-1202.                            home [Last accessed on 2023 Oct 09].
               doi: 10.1056/NEJMoa0908127                      57.  Yao  K,  Uedo  N,  Kamada  T,  et al. Guidelines for endoscopic
                                                                  diagnosis of early gastric cancer. Dig Endosc. 2020;32(5):663-698.
            46.  Schröder FH, Roobol MJ. Dutasteride and prostate cancer.
               N Engl J Med. 2010;363(8):793-795.                 doi: 10.1111/den.13684
               doi: 10.1056/NEJMc100549                        58.  Choi KS, Jun JK, Park EC, et al. Performance of different
                                                                  gastric cancer screening methods in Korea: A population-
            47.  Liu Q, Fan Y, Zeng S,  et al. Volatile organic compounds
               for early detection of prostate cancer from urine. Heliyon.   based study. PLoS One. 2012;7(11):e50041.
               2023;9(6):e16686.                                  doi: 10.1371/journal.pone.0050041
               doi: 10.1016/j.heliyon.2023.e16686              59.  Hauser H, Pack GT. The roentgen diagnosis of malignant
                                                                  tumors of the stomach. Radiology. 1936;26(2):221-233.
            48.  Gao  Q,  Su  X,  Annabi  MH,  et al.  Application  of  urinary
               volatile organic compounds (VOCs) for the diagnosis of      doi: 10.1148/26.2.221
               prostate cancer. Clin Genitourin Cancer. 2019;17(3):183-190.
                                                               60.  Dooley  CP,  Larson  AW,  Stace  NH,  et al.  Double-contrast
               doi: 10.1016/j.clgc.2019.02.003                    barium meal and upper gastrointestinal endoscopy.
                                                                  A comparative study. Ann Intern Med. 1984;101(4):538-545.
            49.  Peng G, Hakim M, Broza YY, et al. Detection of lung, breast,
               colorectal, and prostate cancers from exhaled breath using a      doi: 10.7326/0003-4819-101-4-538
               single array of nanosensors. Br J Cancer. 2010;103(4):542-551.
                                                               61.  Low VH, Levine MS, Rubesin SE, Laufer  I, Herlinger  H.
               doi: 10.1038/sj.bjc.6605810                        Diagnosis of gastric carcinoma: Sensitivity of double-contrast
                                                                  barium studies. AJR Am J Roentgenol. 1994;162(2):329-334.
            50.  Sreekumar  A,  Poisson  LM,  Rajendiran  TM,  et al.
               Metabolomic profiles delineate potential role for sarcosine      doi: 10.2214/ajr.162.2.8310920
               in prostate cancer progression [published correction   62.  Portnoy  LM.  Radiologic Diagnosis of Gastric Cancer:
               appears  in  Nature.  2013  Jul  25;499(7459):504].  Nature.   A  New Outlook.  Berlin:  Springer;  2006.  Available  from:
               2009;457(7231):910-914.
                                                                  https://ebookcentral.proquest.com/lib/ottawa/detail.
               doi: 10.1038/nature07762                           action?docID=304463
            51.  Ahmed  Laskar  A,  Younus  H.  Aldehyde  toxicity  and   63.  Gelfand DW, Hachiya J. The double-contrast examination
               metabolism:  The  role  of  aldehyde  dehydrogenases  in   of the stomach using gas-producing granules and tablets.
               detoxification, drug resistance and carcinogenesis.  Drug   Radiology. 1969;93(6):1381-1382.
               Metab Rev. 2019;51(1):42-64.
                                                                  doi: 10.1148/93.6.1381
               doi: 10.1080/03602532.2018.1555587
                                                               64.  National  Health  Commission  of  The  People’s  Republic  of
            52.  Jackson B, Brocker C, Thompson DC, et al. Update on the   China.  National  guidelines  for  diagnosis  and  treatment
               aldehyde  dehydrogenase  gene  (ALDH)  superfamily.  Hum   of gastric cancer 2022 in China (English version).  Chin J
               Genomics. 2011;5(4):283-303.                       Cancer Res. 2022;34(3):207-237.
               doi: 10.1186/1479-7364-5-4-283                     doi: 10.21147/j.issn.1000-9604.2022.03.04
            53.  Lee  S,  Kim  M,  Ahn  BJ,  Jang  Y. Odorant-responsive   65.  Kubota H, Kotoh T, Masunaga R, et al. Impact of screening
               biological receptors and electronic noses for volatile organic   survey of gastric cancer on clinicopathological features and
               compounds with aldehyde for human health and diseases:   survival: Retrospective study at a single institution. Surgery.
               A perspective review. J Hazard Mater. 2023;455:131555.  2000;128(1):41-47.
               doi: 10.1016/j.jhazmat.2023.131555                 doi: 10.1067/msy.2000.106812
            54.  Janfaza S, Khorsand B, Nikkhah M, Zahiri J. Digging deeper   66.  Mizoue T, Yoshimura T, Tokui N, et al. Prospective study
               into volatile organic compounds associated with cancer. Biol   of  screening for  stomach cancer  in Japan.  Int J Cancer.
               Methods Protoc. 2019;4(1):bpz014.                  2003;106(1):103-107.
               doi: 10.1093/biomethods/bpz014                     doi: 10.1002/ijc.11183
            55.  Leemans M, Bauër P, Cuzuel V, Audureau E, Fromantin I.   67.  Hamashima  C,  Saito  H,  Nakayama  T,  Nakayama  T,
               Volatile organic compounds analysis as a potential novel   Sobue  T.  The  standardized  development  method  of  the
               screening  tool  for  breast  cancer:  A  systematic  review.   Japanese guidelines for cancer screening. Jpn J Clin Oncol.
               Biomark Insights. 2022;17:11772719221100709.       2008;38(4):288-295.
               doi: 10.1177/11772719221100709                     doi: 10.1093/jjco/hyn016
            56.  Cancer Today, n.d. Available from: https://gco.iarc.fr/today/  68.  Polk DB, Peek RM Jr. Helicobacter pylori: Gastric cancer and


            Volume 3 Issue 2 (2024)                         14                                doi: 10.36922/td.2061
   15   16   17   18   19   20   21   22   23   24   25